Eli Lilly to spend about $8B on Loxo Oncology

Business 01/07/19, 07:49

Eli Lilly is spending about $8 billion in cash to buy Loxo Oncology, as the drugmaker bulks up on cancer treatments that target certain gene abnormalities.Loxo Oncology could launch a drug next year and targets an abnormality that occurs in several tumor types, including some lung and thyroid cancers, Lilly ...

End of content

No more pages to load